Bioaccessibility of polycyclic aromatic hydrocarbons in central air conditioner filter dust and its occupational exposure to shopping mall employees

Air conditioner filters become sinks and sources of indoor microplastics fibers

Indoor airborne microplastics fibers (MPFs) are emerging contaminants of growing concern. Nowadays, air conditioners (ACs) are widely used in indoor environments. However, little is known about their impact on the distribution of indoor MPFs. In this study, we first disclosed the prevalence of MPF contamination in filters for indoor split ACs used in living rooms, dormitories, and offices. The average density of microfibers was 1.47-21.4 × 10² items/cm², and a total 27.7-35.0% of fibers were MPFs. Of these fibers, the majority were polyester (45.3%), rayon (27.8%), and cellophane (20.1%). We further tracked the long-term accumulation of MPFs on AC filters in three types of rooms, and demonstrated that dormitories showed relatively heavy accumulation especially after running for 35-42 days. Furthermore, we found that simulative AC filters which had been lined with PET MPFs could effectively release those MPFs into indoor air, propelling them away from the ACs at varying distances. Statistical analysis showed that the estimated daily intake of MPFs (5-5000 μm length) from AC filters would increase gradually with their usage, with the intake volume reaching up to 11.2 ± 2.2-44.0 ± 8.9 items/kg-BW/day by the 70th day, although this number varied among people of different ages. Altogether, these findings suggest that AC filters can act as both a sink and a source of microplastics fibers. Therefore, AC filters should be evaluated not only for their substantial impact on the distribution of indoor airborne MPFs, but also for their role in the prevalence of the related health risks.

Past, present, and future perspectives on the assessment of bioavailability/bioaccessibility of polycyclic aromatic hydrocarbons: A 20-year systemic review based on scientific econometrics

Bioaccessibility/bioavailability (bioac-bioav) is an important criterion in the risk assessment of polycyclic aromatic hydrocarbons (PAHs), especially in the restoration of contaminated sites. Although, the bioac-bioav concept is widely employed in PAH risk assessment for both humans and wildlife, their growth and integration in risk assessment models are seldom discussed. Consequently, the relevant literature listed on Web of Science (WOS)™ was retrieved and analyzed using the bibliometric software Citespace in order to gain a comprehensive understanding of this issue. Due to the limitations of the literature search software, we manually searched the articles about PAHs bioac-bioav that were published before 2000. This stage focuses on research on the distribution coefficient of PAHs between different environmental phases and laid the foundation for the adsorption-desorption of PAHs in subsequent studies of the bioac-bioav of PAHs. The research progress on PAH bioac-bioav from 2000 to the present was evaluated using the Citespace software based on country- and discipline-wise publication volumes and research hotspots. The development stages of PAH bioac-bioav after 2000 were divided into four time segments. The first three segments (2000-2005, 2006-2010, and 2011-2015) focused on the degradation of PAHs and their in vivo (bioavailability)-in vitro (bioaccessibility) evaluation method and risk assessment. Meanwhile, the current (2016-present) research focuses on the establishment of analytical methods for assessing PAH derivatives at environmental concentrations and the optimization of various in vitro digestion methods, including chemical optimization (sorptive sink) and biological optimization (Caco-2 cell). The contents are aimed at supplying researchers with a deeper understanding of the development of PAH bioac-bioav.

Metal-Containing Nanoparticles in Low-Rank Coal-Derived Fly Ash from China: Characterization and Implications toward Human Lung Toxicity

Characterization of nanoparticles (NPs) in coal fly ashes (CFAs) is critical for better understanding the potential health-related risks resulting from coal combustion. Based on single-particle (SP)-inductively coupled plasma mass spectrometry (ICP-MS) coupled with transmission electron microscopy techniques, this study is the first to determine the concentrations and sizes of metal-containing NPs in low-rank coal-derived fly ashes. Despite only comprising a minor component of the studied CFAs by mass, NPs were the dominant fraction by particle number. Fe- and Ti-containing NPs were identified as the dominant NPs with their particle number concentration ranging from 2.5 × 10⁷ to 2.5 × 10⁸ particles/mg. In addition, the differences of Fe-/Ti-containing NPs in various CFAs were regulated by the coalification degree of feed coals and combustion conditions of all of the low-rank CFAs tested. In the cases where these NPs in CFAs become airborne and are inhaled, they can be taken up in pulmonary interstitial fluids. This study shows that in Gamble's solution (a lung fluid simulant), 51-87% of Fe and 63-89% of Ti (ratio of the mass of Fe-/Ti-containing NPs to the total mass of Fe/Ti) exist in the NP form and remain suspended in pulmonary fluid simulants. These NPs are bioavailable and may induce lung tissue damage.

Bioaccessibilities of metal(loid)s and organic contaminants in particulates measured in simulated human lung fluids: A critical review

Particle-bound pollutants can pose a health risk to humans. Inhalation exposure evaluated by total contaminant concentrations significantly overestimates the potential risk. To assess the risk more accurately, bioavailability, which is the fraction that enters into the systemic circulation, should be considered. Researchers have replaced bioavailability by bioaccessibility due to the rapid and cost-efficient measurement for the latter, especially for assessment by oral ingestion. However, contaminants in particulates have different behavior when inhaled than when orally ingested. Some of the contaminants are exhaled along with exhalation, and others are deposited in the lung with the particulates. In addition, a fraction of the contaminants is released into the lung fluid and absorbed by the lung, and another fraction enters systemic circulation under the action of cell phagocytosis on particulates. Even if the release fraction, i.e., release bioaccessibility, is considered, the measurement faces many challenges. The present study highlights the factors influencing release bioaccessibility and the incorporation of inhalation bioaccessibility into the risk assessment of inhaled contaminants. Currently, there are three types of extraction techniques for simulated human lung fluids, including simple chemical solutions, sequential extraction techniques, and physiologically based techniques. The last technique generally uses three kinds of solution: Gamble's solution, Hatch's solution, and artificial lysosomal fluid, which are the most widely used physiologically based simulated human lung fluids. External factors such as simulated lung fluid composition, pH, extraction time, and sorption sinks can affect release bioaccessibility, whereas particle size and contaminant properties are important internal factors. Overall, release bioaccessibility is less used than bioaccessibility considering the deposition fraction when assessing the risk of contaminants in inhaled particulates. The release bioaccessibility measurement poses two main challenges: developing a unified, accurate, stable, simple, and systematic biologically based method, and validating the method through in-vivo assays.